Henry Schein (HSIC) Scheduled to Post Quarterly Earnings on Tuesday
Henry Schein (NASDAQ:HSIC) will be issuing its quarterly earnings data on Tuesday, May 6th. Henry Schein has set its FY14 guidance at $5.29-5.39 EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 11th. The company reported $1.43 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.39 by $0.04. The company had revenue of $2.50 billion for the quarter, compared to the consensus estimate of $2.53 billion. During the same quarter last year, the company posted $1.26 earnings per share. Henry Schein’s revenue was up 4.9% compared to the same quarter last year. On average, analysts expect Henry Schein to post $5.37 EPS for the current fiscal year and $5.96 EPS for the next fiscal year.
Shares of Henry Schein (NASDAQ:HSIC) opened at 113.94 on Monday. Henry Schein has a one year low of $89.57 and a one year high of $120.99. The stock’s 50-day moving average is $115.8 and its 200-day moving average is $114.7. The company has a market cap of $9.735 billion and a price-to-earnings ratio of 23.18.
A number of analysts have recently weighed in on HSIC shares. Analysts at Ned Davis Research upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating in a research note on Monday, March 10th. On a related note, analysts at Zacks reiterated a “neutral” rating on shares of Henry Schein in a research note on Friday, March 7th. They now have a $126.00 price target on the stock. Finally, analysts at Piper Jaffray raised their price target on shares of Henry Schein from $113.00 to $118.00 in a research note on Wednesday, February 12th. Two research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Henry Schein presently has an average rating of “Buy” and a consensus target price of $111.00.
Henry Schein, Inc is a provider of health care products and services to office-based practitioners. It conducts its business through two segments: healthcare distribution and technology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.